Skip to content
TrialScanner

NCT02121873

The Breast Duct: Pilot Study of Genomic Sequencing of Exfoliated Ductal Cells Obtained Through Endoscopy and Lavage

No phase registeredCompletedATOSLeadILMNCollaborator

Registry record

Lead sponsor
Atossa Therapeutics, Inc.
Conditions
Breast Cancer; Preneoplastic Conditions; Ductal Carcinoma in Situ
Primary completion
Sep 2011Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT02121873 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT02121873: The Breast Duct: Pilot Study... | TrialScanner